Clinical Trials Browser

INDUSTRY × Glioblastoma × Standard of Care × Clear all

NCT04485949 2026-02-10

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

Phase 2 Active not recruiting

Glioblastoma

NCT03393000 2021-07-22

INTACT

Phase 3 Terminated

19 enrolled 8 charts

Glioblastoma

NCT04450160 2020-06-29

AEO

Phase 2 Unknown

Glioblastoma, Seizures